当前位置:首页 - 行情中心 - 海正药业(600267) - 财务分析 - 利润表

海正药业

(600267)

  

流通市值:91.65亿  总市值:92.89亿
流通股本:11.92亿   总股本:12.08亿

利润表

报告期2023-09-302023-06-302023-03-312022-12-31
公司类型通用通用通用通用
一、营业总收入8,700,895,404.716,060,103,056.033,063,534,009.2212,036,690,081.66
营业收入8,700,895,404.716,060,103,056.033,063,534,009.2212,036,690,081.66
二、营业总成本8,115,484,387.675,564,001,745.742,778,135,602.1211,255,665,737.91
营业成本5,107,548,811.013,541,502,539.921,830,728,132.676,998,674,056.8
税金及附加59,771,906.0433,002,412.5623,767,446.02107,297,080.5
销售费用1,804,226,005.131,236,609,099.58548,317,890.422,406,084,917.47
管理费用683,261,527.15439,720,628.18222,386,372.591,052,167,892.32
研发费用311,937,379.73210,712,020.4697,041,933.9428,693,511.53
财务费用148,738,758.61102,455,045.0455,893,826.52262,748,279.29
其中:利息费用166,603,909.22114,496,523.5256,524,961.92283,123,781.13
其中:利息收入17,151,892.5310,775,621.825,009,916.0526,506,390.56
加:公允价值变动收益1,398,660.11163,740.031,547,057.58-107,317,563.23
加:投资收益71,828,219.9398,437,053.227,610,239.9325,065,751.23
资产处置收益-14,833,894.53-1,196,608.9715,277,919.36-496,474.43
资产减值损失(新)-65,712,581.28-66,665,216.32-17,797,649.97-126,037,025.94
信用减值损失(新)-22,366,724.09-30,356,278.99-19,644,058.319,525,675.23
其他收益73,344,380.7653,772,416.0123,370,830.13100,713,715.51
营业利润平衡项目0000
四、营业利润629,069,077.94550,256,415.27295,762,745.82682,478,422.12
加:营业外收入962,829.39828,936.2650,202.678,472,159.82
减:营业外支出49,232,609.0547,582,543.2166,3277,527,896.64
利润总额平衡项目0000
五、利润总额580,799,298.28503,502,808.33295,646,621.49683,422,685.3
减:所得税费用107,884,880.4472,395,627.7254,114,396.98192,003,207.45
六、净利润472,914,417.84431,107,180.61241,532,224.51491,419,477.85
持续经营净利润472,914,417.84431,107,180.61241,532,224.51491,419,477.85
归属于母公司股东的净利润457,097,549.01419,411,807.41232,298,844.11489,045,084.28
少数股东损益15,816,868.8311,695,373.29,233,380.42,374,393.57
(一)基本每股收益0.390.370.190.42
(二)稀释每股收益0.390.330.170.42
八、其他综合收益2,079,722.813,165,501.87-1,388,894.9110,594,557.81
归属于母公司股东的其他综合收益2,079,722.813,165,501.87-1,388,894.9110,594,557.81
九、综合收益总额474,994,140.65434,272,682.48240,143,329.6502,014,035.66
归属于母公司股东的综合收益总额459,177,271.82422,577,309.28230,909,949.2499,639,642.09
归属于少数股东的综合收益总额15,816,868.8311,695,373.29,233,380.42,374,393.57
公告日期2023-10-282023-08-222023-04-252023-03-31
审计意见(境内)标准无保留意见
TOP↑